Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Acumen Pharmaceuticals, Inc. (ABOS) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
-- |
|
$-102.33M |
|
-- |
|
-- |
|
$114.02M |
|
$-114.02M |
|
$11.69M |
|
$-102.33M |
|
$-102.33M |
|
$-102.33M |
|
$-102.33M |
|
$-102.33M |
|
$-102.33M |
|
$-114.02M |
|
$-118.85M |
|
60.01M |
|
60.01M |
|
$-1.71 |
|
$-1.71 |
|
| Balance Sheet Financials | |
$178.31M |
|
-- |
|
$60.69M |
|
$238.99M |
|
$27.61M |
|
$29.42M |
|
$29.57M |
|
$57.18M |
|
$181.82M |
|
$181.82M |
|
$181.82M |
|
60.09M |
|
| Cash Flow Statement Financials | |
$-86.22M |
|
$48.03M |
|
$6.93M |
|
$67.12M |
|
$35.86M |
|
$-31.26M |
|
$9.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.46 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
0.14 |
|
0.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-86.23M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-56.28% |
|
-56.28% |
|
-42.82% |
|
-48.44% |
|
$3.03 |
|
$-1.44 |
|
$-1.44 |
|